IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
